J7184 Insurance Policy Changes

IVIG (immune globulin) (Revised)

This is a historical policy document (issued 2026-01-01, discovered 2026-10-06) establishing Humana Medicaid Ohio's IVIG (immune globulin) prior authorization requirements across 25 product formulations and 24 clinical indications. The policy specifies preferred products, step-therapy rules, and approval criteria for conditions ranging from primary immunodeficiency to autoimmune diseases. Since this policy became effective on 2026-01-01 and is now 9 months past implementation, verify current applicability with Humana before applying these requirements.